Fovea Pharmaceuticals was set up in 2005 to research and develop drugs for treating ophthalmologic disorders, such as age-related macular degeneration, retinitis pigmentosa and diabetic retinopathy. Fovea has developed a range of products in different stages of testing, from pre-clinical products to products about to undergo clinical testing. Over recent years Fovea has signed exclusive cooperation agreements with CombinatorRx Inc. and Novartis.
- Activity: Ophthalmologic disorder drugs
- Website: www.fovea-pharma.com
- Location: France
- Entry: 2005
- Platform: Health & Care